Dongwha Pharm's 'Fucid Cream' Surpasses 10 Billion KRW in Cumulative Sales 7 Months After Launch

Dongwha Pharm Hucid Cream.

[Asia Economy Reporter Lee Gwan-joo] Dongwha Pharm announced on the 20th that its functional cosmetic product, 'Husid Cream,' has achieved cumulative sales of 10 billion KRW within seven months of its launch.

Husid Cream was exclusively launched through GS Home Shopping last October and has sold out multiple times. It surpassed 400,000 units in cumulative sales within three months of release and has continued to attract high interest, reaching 770,000 units sold to date.

A Dongwha Pharm representative stated, "Following the recent lifting of the outdoor mask mandate, the need for healthy skin care has increased, drawing attention to the derma cosmetic market. The achievement of 10 billion KRW in sales within seven months of Husid Cream's launch is thanks to consumers recognizing the excellent product quality of Husid Cream."

Husid Cream is a derma cosmetic product containing microbiome ingredients, with a high concentration of 38.9% of the 'Husiderm' component, which helps improve skin density. 'Husiderm' is a patented skincare ingredient newly researched and developed from 'Fusidium Coccineum,' which shares the same origin and components as Dongwha Pharm's 'Husidin.' Non-human tests have confirmed its effects in increasing collagen production, inhibiting elastase enzyme activity, and enhancing hyaluronic acid synthase production.

This content was produced with the assistance of AI translation services.